EFFECT OF DIVALENT IONS ON THE ACTIVITY OF CANCER PROCOAGULANT

被引:9
|
作者
MIELICKI, WP
KOZWICH, DL
KRAMER, LC
GORDON, SG
机构
[1] UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262
[2] MED UNIV LODZ,INST ENVIRONM RES & BIOANAL,DEPT BIOCHEM,PL-90151 LODZ,POLAND
关键词
BLOOD COAGULATION; CANCER PROCOAGULANT; DIVALENT IONS; CALCIUM; MANGANESE; MAGNESIUM; IRON; ZINC;
D O I
10.1006/abbi.1994.1425
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of calcium (Ca2+), magnesium (Mg2+), manganese (Mn2+), iron (Fe2+), and zinc (Zn2+) on the factor X-activating activity of cancer procoagulant (CP) was studied. Activity of CP was evaluated with a three-stage chromogenic assay (liquid-phase assay, ''native'' CP) and with an immunocapture enzyme (ICE) assay (solid-phase assay, immobilized CP). In the liquid-phase assay, CP activity was Ca2+-dependent, and Mg2+ (5 mM) or Mn2+ (0.01-0.1 mM) could substitute for Ca2+. There was no additive effect of Mg2+ and Ca2+ on the activity of CP. Activity of CP in the liquid-phase assay, in the presence of 7 mM Ca2+, was enhanced by 0.1 mM Mn2+ to about 240% of the activity observed when only Ca2+ was present in the reaction, Zn2+ and Fe2+ did not activate CP in the absence of Ca2+; they inhibited CP activity in a concentration-dependent mode when administered in the presence of Ca2+. The activity of CP evaluated by the solid-phase assay (ICE assay) was neither Ca2+-dependent nor was it susceptible to potentiation by Mn2+ administered after CP was bound to IgM. CP exposed to 5 mM Mn2+ before binding to IgM expressed about 85% higher activity than without the presence of Mn2+. When CP was first preincubated with divalent ion and then immunocaptured, the signal generated in the enzyme-linked immunoadsorbent assay by Mn2+-containing CP was significantly different (30% greater) than signals generated by CP without Mn2+ or containing different ion. These data suggest that: (1) there is a significant conformational change of the CP molecule that takes place after capturing CP by the monoclonal IgM antibody on the solid surface; (2) the divalent ions are not directly involved in enzyme-substrate interactions in the CP moiety; and (3) the interaction of Mn2+ with CP seems to be different from that of the other divalent ions. (C) 1994 Academic Press, Inc.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 50 条
  • [41] EFFECT OF DIVALENT CATIONS ON ACTIVITY OF BACTERIAL UREASE
    JONES, GA
    CANADIAN JOURNAL OF MICROBIOLOGY, 1965, 11 (01) : 120 - &
  • [42] CANCER PROCOAGULANT - A NOVEL VITAMIN-K-DEPENDENT ACTIVITY
    DONATI, MB
    DELAINI, F
    COLUCCI, M
    DEVITTI, G
    LOCATI, D
    POGGI, A
    SEMERARO, N
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 33 - 33
  • [43] Cancer procoagulant activity studies using synthetic peptidyl substrates
    Mielicki, WP
    Mielicka, E
    Gordon, SG
    THROMBOSIS RESEARCH, 1997, 87 (02) : 251 - 256
  • [44] CANCER PROCOAGULANT A (CBA) ACTIVITY IN CULTURED NORMAL AND TRANSFORMED FIBROBLASTS
    LEWIS, BJ
    GORDON, SG
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 1082 - 1082
  • [45] CANCER PROCOAGULANT
    GORDON, SG
    PROTEOLYTIC ENZYMES: SERINE AND CYSTEINE PEPTIDASES, 1994, 244 : 568 - 583
  • [46] Effect of Divalent Metal Ions on the Ribonuclease Activity of the Toxin Molecule HP0894 from Helicobacter pylori
    Hyun, Ja-Shil
    Pun, Rabin
    Park, Sung Jean
    Lee, Bong-Jin
    LIFE-BASEL, 2024, 14 (02):
  • [47] ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND CANCER PROCOAGULANT ACTIVITY
    POGLIANI, EM
    LANZAFAME, C
    BUCCIARELLI, P
    CORNEO, G
    HAEMATOLOGICA, 1991, 76 (06) : 526 - 527
  • [48] High expression of glycosphingolipids involved in procoagulant activity of cancer cells
    Suzuki, M
    Ando, O
    Ohta, T
    Inufusa, H
    Adachi, T
    Yasutomi, M
    Kurimoto, M
    ONCOLOGY REPORTS, 1999, 6 (01) : 113 - 115
  • [49] The effect of cancer procoagulant on extracellular matrix protein degradation
    Kee, N. Low Ah
    Naude, R. J.
    Frost, C. L.
    Mielicki, W. P.
    Blatch, G. L.
    FEBS JOURNAL, 2008, 275 : 238 - 238
  • [50] MONOCYTE PROCOAGULANT ACTIVITY (MPCA) IN CANCER-PATIENTS INVITRO
    MULLER, M
    FLOSSEL, C
    SPECKMANN, FR
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (11): : 1403 - 1403